The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Response adapted oncologic surgery following neoadjuvant immunotherapy and chemotherapy for resectable locally advanced oral cavity and oropharyngeal squamous cell carcinoma.
 
Moneb Bughrara
No Relationships to Disclose
 
Francis Worden
Honoraria - Eisai; Exelixis; Merck Sharp & Dohme; Merus; PDS Biotechnology; Sun Pharma Advanced Research Company
Consulting or Advisory Role - Adlai Nortye; Coherus Biosciences; Coherus Biosciences; Exelixis; Merck; PDS Biotechnology; Sun Pharma Advanced Research Company
Research Funding - Adlai-Nordlyte; Coherus Biosciences; CUE Biopharma (Inst); EpicentRx; Loxo/Lilly (Inst); Merck (Inst); PDS Biotechnology
Travel, Accommodations, Expenses - Merck Sharp & Dohme; Sun Pharma Advanced Research Company
 
Zachary Buxo
No Relationships to Disclose
 
Colleen Hochfelder
No Relationships to Disclose
 
Steven Chinn
No Relationships to Disclose
 
Michelle Mierzwa
Consulting or Advisory Role - Adaptimmune
Research Funding - Debiopharm Group
 
Jennifer Shah
Employment - Trinity Health (I); University of Michigan Health System
Leadership - University of Michigan Health System
Research Funding - Tactile Medical
 
Keith Casper
No Relationships to Disclose